Eastman Completes Sale of Performance Polymers PET Business

Eastman Chemical Company (NYSE:EMN) announced that it has completed the previously announced sale of its Performance Polymers segment's PET business, related assets, and technology to DAK Americas, LLC.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The total cash proceeds of the transaction were $600 million, subject to post-closing adjustment for working capital. The company will recognize a modest gain from the sale in first quarter 2011.

The divestiture, which includes the company's Performance Polymers segment assets at its Columbia, South Carolina site, will not impact product lines in the company's Specialty Plastics segment.

Eastman's chemicals, fibers and plastics are used as key ingredients in products that people use every day. Approximately 10,000 Eastman employees around the world blend technical expertise and innovation to deliver practical solutions. The company is committed to finding sustainable business opportunities within the diverse markets and geographies it serves. A global company headquartered in Kingsport, Tenn., USA, Eastman had 2010 sales of $5.8 billion.
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report